News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
846,865 Results
Type
Article (86496)
Company Profile (702)
Press Release (759667)
Multimedia
Podcasts (130)
Webinars (14)
Section
Business (232686)
Career Advice (4127)
Deals (39721)
Drug Delivery (129)
Drug Development (90985)
Employer Resources (198)
FDA (18107)
Job Trends (17335)
News (396465)
Policy (39748)
Tag
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (56838)
ALS (102)
Alzheimer's disease (1504)
Antibody-drug conjugate (ADC) (161)
Approvals (18069)
Artificial intelligence (331)
Autoimmune disease (30)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (309)
Cancer (2471)
Cardiovascular disease (210)
Career advice (3535)
Career pathing (34)
CAR-T (175)
Cell therapy (498)
Cervical cancer (22)
Clinical research (73453)
Collaboration (928)
Company closure (1)
Compensation (572)
Complete response letters (30)
COVID-19 (2868)
CRISPR (50)
C-suite (274)
Cystic fibrosis (109)
Data (2338)
Decentralized trials (2)
Denatured (45)
Depression (57)
Diabetes (303)
Diagnostics (6926)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (129)
Drug shortages (33)
Duchenne muscular dystrophy (103)
Earnings (96830)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (130153)
Executive appointments (785)
FDA (19498)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (829)
Gene editing (125)
Generative AI (35)
Gene therapy (365)
GLP-1 (858)
Government (5164)
Grass and pollen (6)
Guidances (108)
Healthcare (20888)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (150)
Indications (30)
Infectious disease (3032)
Inflammatory bowel disease (159)
Inflation Reduction Act (11)
Influenza (59)
Intellectual property (102)
Interviews (813)
IPO (17821)
IRA (51)
Job creations (5188)
Job search strategy (2861)
Kidney cancer (11)
Labor market (43)
Layoffs (559)
Leadership (24)
Legal (10114)
Liver cancer (82)
Lung cancer (347)
Lymphoma (160)
Machine learning (8)
Management (65)
Manufacturing (366)
MASH (78)
Medical device (14641)
Medtech (14646)
Mergers & acquisitions (22454)
Metabolic disorders (803)
Multiple sclerosis (88)
NASH (23)
Neurodegenerative disease (117)
Neuropsychiatric disorders (34)
Neuroscience (2119)
NextGen: Class of 2025 (7682)
Non-profit (5082)
Now hiring (40)
Obesity (431)
Opinion (275)
Ovarian cancer (80)
Pain (104)
Pancreatic cancer (91)
Parkinson's disease (162)
Partnered (24)
Patents (256)
Patient recruitment (118)
Peanut (51)
People (65329)
Pharmaceutical (143)
Pharmacy benefit managers (22)
Phase I (22667)
Phase II (31893)
Phase III (24028)
Pipeline (1329)
Policy (175)
Postmarket research (3552)
Preclinical (10230)
Press Release (72)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (434)
Real estate (7392)
Recruiting (75)
Regulatory (26823)
Reports (57)
Research institute (2658)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (82)
Series A (143)
Series B (94)
Service/supplier (30)
Sickle cell disease (59)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4293)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (51)
The Weekly (83)
Vaccines (818)
Venture capitalists (44)
Weight loss (306)
Women's health (40)
Worklife (20)
Date
Today (295)
Last 7 days (905)
Last 30 days (3132)
Last 365 days (35792)
2025 (12404)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (60)
Alaska (7)
Arizona (269)
Arkansas (14)
Asia (50153)
Australia (8831)
California (6578)
Canada (2086)
China (570)
Colorado (287)
Connecticut (304)
Delaware (165)
Europe (115070)
Florida (957)
Georgia (222)
Hawaii (1)
Idaho (64)
Illinois (639)
India (31)
Indiana (338)
Iowa (12)
Japan (174)
Kansas (111)
Kentucky (28)
Louisiana (15)
Maine (70)
Maryland (981)
Massachusetts (5049)
Michigan (251)
Minnesota (427)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (67)
New Hampshire (70)
New Jersey (1854)
New Mexico (31)
New York (1855)
North Carolina (1143)
North Dakota (9)
Northern California (2822)
Ohio (223)
Oklahoma (15)
Oregon (48)
Pennsylvania (1449)
Puerto Rico (13)
Rhode Island (36)
South America (1653)
South Carolina (26)
South Dakota (1)
Southern California (2435)
Tennessee (106)
Texas (990)
United States (25221)
Utah (196)
Virginia (176)
Washington D.C. (72)
Washington State (611)
West Virginia (3)
Wisconsin (72)
There are 846,865 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Moleculin to Report First Quarter 2025 Financial Results on May 13, 2025 and Host Conference Call and Webcast
May 7, 2025
·
4 min read
Press Releases
Pramana Strengthens Scientific Leadership with Addition of Dr. Adrian Noriega to Advance Neurodegenerative Pipeline
May 7, 2025
·
2 min read
Press Releases
e-therapeutics Presents New Data Supporting ETX‑312 as a Differentiated and Disease-Modifying Near-Clinic Treatment for MASH
May 7, 2025
·
3 min read
Press Releases
Alkeus Pharmaceuticals Presents Gildeuretinol Data During the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting May 4-8, 2025
May 7, 2025
·
5 min read
Press Releases
Jaguar Health Provides Overview of 2025 Crofelemer-Related Catalysts
May 7, 2025
·
7 min read
Press Releases
Major Study Shows Liver Health Measured with cT1 Predicts Clinical Outcomes
May 7, 2025
·
5 min read
Press Releases
Uviquity Emerges from Stealth with $6.6M Seed Funding to Develop Breakthrough Far-UVC Semiconductor Technology for Human-Safe Photonic Disinfection
May 7, 2025
·
3 min read
Layoff Tracker
NGM Terminates 85 as Lead Asset Moves Through Registrational Study
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
May 7, 2025
·
193 min read
·
BioSpace Editorial Staff
Gene therapy
CRISPR’s Casgevy on the Rise With More Gene Therapy Proof of Concept To Come in 2025
CRISPR Therapeutics’ partner Vertex reported that more than 65 treatment centers have been activated for the gene therapy Casgevy. While Vertex handles the market, CRISPR has been focused on its clinical program.
May 7, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
Altesa BioSciences Details Positive Topline Vapendavir Results from Phase 2 Placebo-Controlled Rhinovirus Challenge Study in COPD Patients
May 7, 2025
·
5 min read
1 of 84,687
Next
